Joep J. de Jong

910 total citations
35 papers, 384 citations indexed

About

Joep J. de Jong is a scholar working on Surgery, Oncology and Urology. According to data from OpenAlex, Joep J. de Jong has authored 35 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 7 papers in Oncology and 6 papers in Urology. Recurrent topics in Joep J. de Jong's work include Bladder and Urothelial Cancer Treatments (33 papers), Urinary and Genital Oncology Studies (25 papers) and Epigenetics and DNA Methylation (5 papers). Joep J. de Jong is often cited by papers focused on Bladder and Urothelial Cancer Treatments (33 papers), Urinary and Genital Oncology Studies (25 papers) and Epigenetics and DNA Methylation (5 papers). Joep J. de Jong collaborates with scholars based in Netherlands, United States and Canada. Joep J. de Jong's co-authors include Joost L. Boormans, Ewan A. Gibb, Kees Hendricksen, Hugh Mostafid, Roland Seiler, Ellen C. Zwarthoff, Elai Davicioni, Peter C. Black, Yair Lotan and Geert J.L.H. van Leenders and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Joep J. de Jong

29 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joep J. de Jong Netherlands	13	334	99	72	70	69	35	384
Hugh Mostafid United Kingdom	8	274 0.8×	79 0.8×	69 1.0×	63 0.9×	85 1.2×	26	345
Chih‐Hsiung Kang Taiwan	9	286 0.9×	47 0.5×	81 1.1×	113 1.6×	60 0.9×	17	377
Angela Qu United States	6	232 0.7×	63 0.6×	93 1.3×	99 1.4×	49 0.7×	18	301
Ashish M. Kamat United States	10	546 1.6×	89 0.9×	109 1.5×	99 1.4×	175 2.5×	15	576
Aleksandra Klim United States	8	181 0.5×	73 0.7×	38 0.5×	74 1.1×	80 1.2×	12	321
Priscilla Baez United States	4	234 0.7×	142 1.4×	89 1.2×	77 1.1×	23 0.3×	5	328
Petter Kollberg Sweden	8	292 0.9×	66 0.7×	72 1.0×	81 1.2×	57 0.8×	16	312
Amiel E. Gilad Israel	4	280 0.8×	24 0.2×	78 1.1×	101 1.4×	118 1.7×	6	371
Sally Hanna Canada	6	255 0.8×	36 0.4×	83 1.2×	71 1.0×	43 0.6×	10	309
Dina Johnson United States	7	261 0.8×	89 0.9×	135 1.9×	64 0.9×	16 0.2×	9	384

Countries citing papers authored by Joep J. de Jong

Since Specialization

Citations

This map shows the geographic impact of Joep J. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joep J. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joep J. de Jong more than expected).

Fields of papers citing papers by Joep J. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joep J. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joep J. de Jong. The network helps show where Joep J. de Jong may publish in the future.

Co-authorship network of co-authors of Joep J. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Joep J. de Jong. A scholar is included among the top collaborators of Joep J. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joep J. de Jong. Joep J. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jong, Joep J. de, Siamak Daneshmand, Robert S. Svatek, et al.. (2025). Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy. European Urology Open Science. 73. 24–30. 1 indexed citations

Tateo, Valentina, Joep J. de Jong, Brigida Anna Maiorano, et al.. (2025). Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 31(16). 3503–3511.

Jong, Joep J. de, Yair Lotan, Roland Seiler, et al.. (2025). Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy. Clinical Cancer Research. 31(19). 4174–4183.

Jong, Joep J. de, Peter C. Black, Lars Dyrskjøt, & Ewan A. Gibb. (2025). Long Noncoding RNAs Identify a Subgroup of Patients with Low-grade Non–muscle-invasive Bladder Cancer with Less Favorable Outcomes. European Urology Oncology. 8(4). 879–882.

Jong, Joep J. de, et al.. (2024). Upper tract urothelial cancer (UTUC) genomic profiling and correlation regarding benefit of platinum-based chemotherapy. SHILAP Revista de lepidopterología. 5(6). 1261–1270.

Jong, Joep J. de, Tarek A. Bismar, Stephen A. Boorjian, et al.. (2024). Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers. Urologic Oncology Seminars and Original Investigations. 42(6). 177.e5–177.e14. 1 indexed citations

Jong, Joep J. de, Siamak Daneshmand, Robert S. Svatek, et al.. (2024). A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy. British Journal of Urology. 135(4). 648–656. 1 indexed citations

Jong, Joep J. de, Yair Lotan, & Joost L. Boormans. (2024). Re: EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. European Urology. 86(5). 480–481. 2 indexed citations

Devlies, Wout, Joep J. de Jong, Fabian Hofmann, et al.. (2023). The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office. European Urology Focus. 10(1). 115–122. 16 indexed citations

10.

Jong, Joep J. de, Begoña P. Valderrama, Júlia Perera‐Bel, et al.. (2022). Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis. British Journal of Cancer. 127(2). 313–320. 13 indexed citations

11.

Jong, Joep J. de, Hans Stoop, Joost L. Boormans, & Geert J.L.H. van Leenders. (2021). PD-L1 expression in urothelial bladder cancer varies more among specimen types than between companion assays. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(4). 705–713. 4 indexed citations

12.

Jong, Joep J. de, Vikram M. Narayan, Andrea A. Cronican, et al.. (2021). Gene Expression Profiling of Muscle-Invasive Bladder Cancer With Secondary Variant Histology. American Journal of Clinical Pathology. 156(5). 895–905. 7 indexed citations

13.

Necchi, Andrea, Daniele Raggi, Andrea Gallina, et al.. (2021). Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition. Urologic Oncology Seminars and Original Investigations. 39(10). 734.e11–734.e17. 5 indexed citations

14.

Hendricksen, Kees, et al.. (2021). Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 40(2). 62.e13–62.e20. 28 indexed citations

15.

Jalanko, Tuomas, Joep J. de Jong, Ewan A. Gibb, Roland Seiler, & Peter C. Black. (2020). Genomic Subtyping in Bladder Cancer. Current Urology Reports. 21(2). 16–16. 21 indexed citations

16.

Woldu, Solomon L., Casey K. Ng, Ronald K. Loo, et al.. (2020). Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. The Journal of Urology. 205(5). 1387–1393. 13 indexed citations

17.

Kessel, Kim E.M. van, Joep J. de Jong, Angelique C. J. Ziel-van der Made, et al.. (2020). A Urine Based Genomic Assay to Triage Patients with Hematuria for Cystoscopy. The Journal of Urology. 204(1). 50–57. 16 indexed citations

18.

Jong, Joep J. de, Yang Liu, A. Gordon Robertson, et al.. (2019). Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis. Genome Medicine. 11(1). 60–60. 44 indexed citations

19.

Genitsch, Vera, Attila Kollár, Gillian Vandekerkhove, et al.. (2019). Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 37(11). 826–836. 32 indexed citations

20.

Jong, Joep J. de, Teun van Gelder, J. IJzermans, Hubert P. Endtz, & Willem Weimar. (1999). Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient. Transplant International. 12(1). 71–73. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact